zm 241385 has been researched along with Chronic Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, P; Huang, S; Liu, X; Luo, X; Qi, J; Shen, X; Wang, J; Yang, Z; Zhong, Y | 1 |
| Ackerman, Z; Avraham, Y; Berry, EM; Magen, I; Mechoulam, R; Vorobiev, L | 1 |
2 other study(ies) available for zm 241385 and Chronic Disease
| Article | Year |
|---|---|
The Effect of A2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma.
Topics: Adenosine A2 Receptor Antagonists; Animals; Blotting, Western; Cell Count; Cells, Cultured; Chronic Disease; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Glaucoma; Immunohistochemistry; Intravitreal Injections; Male; Microglia; Ocular Hypertension; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Retinal Ganglion Cells; RNA; Triazines; Triazoles | 2016 |
Cannabidiol ameliorates cognitive and motor impairments in mice with bile duct ligation.
Topics: Adenosine A2 Receptor Antagonists; Animals; Bile Ducts; Brain-Derived Neurotrophic Factor; Cannabidiol; Chronic Disease; Cognition; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Female; Gait Disorders, Neurologic; Hepatic Encephalopathy; Ligation; Liver Diseases; Mice; Mice, Inbred Strains; Motor Activity; Receptor, Adenosine A2A; Receptors, Tumor Necrosis Factor, Type I; RNA, Messenger; Treatment Outcome; Triazines; Triazoles | 2009 |